KLINICKÁ FARMAKOLOGIE A FARMACIE / Klin Farmakol Farm. 2026;40(1):19-24 / www.klinickafarmakologie.cz 24 HLAVNÍ TÉMA Alergenová imunoterapie inhalačních alergií LITERATURA 1. EAACI. The European Academy of Allergy and Clinical Immunology Advocacy Manifesto [Internet]. EAACI; 2024 [cited 2026-01-06]. Available from: https://eaaci.org/wp-content/ uploads/2024/02/EAACI_Advocacy_Manifesto.pdf. 2. Muraro A, et al. Allergen Immunotherapy Guidelines Part 1: Systematic reviews. EAACI; 2017. ISBN 978-3-9524815-0-9. 3. Rybníček O, Seberová E. Průvodce alergenovou imunoterapií: doporučení České společnosti alergologie a klinické imunologie ČLS JEP. Praha: Tigis; 2021. 4. Muraro A, Roberts G. Allergen Immunotherapy Guidelines Part 2: Recommendations. EAACI; 2017. ISBN 978-3-9524815-1-6. 5. Státní ústav pro kontrolu léčiv. Souhrny údajů o přípravku (SPC) registrovaných terapeutických alergenů [Internet]. Státní ústav pro kontrolu léčiv. [cited 2026-01-06]. Available from: https://www.sukl.cz. 6. Passalacqua G. Sublingual immunotherapy: World Allergy Organization Position Paper 2014. World Allergy Organ J. 2014;7(1):21. 7. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J. 2015;8(1):17. 8. Viswanathan RK, Busse WW. Allergen Immunotherapy in Allergic Respiratory Diseases: From Mechanisms to Meta-analyses. Chest. 2012;141(5):1303-1314. 9. Cappella A, Durham SR. Allergen immunotherapy for allergic respiratory diseases. Hum Vaccin Immunother. 2012;8(10):1499-1512. 10. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2017 update [Internet]. Global Initiative for Asthma; 2017 [cited 2026-01-06]. Available from: https://ginasthma.org. 11. Devillier P, Dreyfus JF, Demoly P, et al. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med. 2014;12:71. 12. Nevrlka J. Hodnocení efektu alergenové imunoterapie v rámci léčby respiračních alergií. Vnitř Lék. 2025;71(7):468-472. 13. Pfaar O, Demoly P, Gerth van Wijk R, et al; European Academy of Allergy and Clinical Immunology. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854-867. 14. Kappen J, Diamant Z, Agache I, et al. Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper. Allergy. 2023;78(11):2835-2850. 15. Gradman J, Halken S. Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations. J Allergy Clin Immunol Pract. 2021;9(5):1813-1817. 16. Asaria M, Dhami S, van Ree R, et al. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview. Allergy. 2018;73(2):269-283. 17. Klimek L, et al. ARIA guideline 2019: treatment of allergic rhinitis in the precision medicine era. Allergy. 2019;74(12): 2386-2398. 18. Cirillo I, Marseglia G, Klersy C, et al. Allergic patients have more numerous and prolonged respiratory infections than nonallergic subjects. Allergy. 2007;62(9):1087-1090. 19. Incorvaia C, Rapetti A, Scurati S, et al. Importance of patient‘s education in favouring compliance with sublingual immunotherapy. Allergy. 2010;65(10):1341-1342.
RkJQdWJsaXNoZXIy NDA4Mjc=